Preimplantation Genetics Diagnosis (PGD) Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Global Preimplantation Genetics Diagnosis (PGD) Market is estimated to reach $140 Million by 2027; growing at a CAGR of 6% from 2021-2027. 

Preimplantation genetic diagnosis (PGD), also known as embryo screening, is a branch of genetics that involves genetic testing of embryos through in vitro fertilization (IVF). PGD ​​eliminates the risk of selective abortion in couples at significant risk of passing on serious genetic, chromosomal, or genetic disorders such as spinal muscular atrophy and cystic fibrosis.

Market Segments

By Test Type

• Chromosomal abnormalities
• Gender selection
• X-linked diseases
• Aneuploidy
• Single gene disorders
• Others

Key Players

• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• Laboratory Corporation of America Holdings (LabCorp)
• Natera, Inc.
• PerkinElmer, Inc.

Scope of the Report

The research study analyzes the global Preimplantation Genetics Diagnosis (PGD) industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Preimplantation Genetics Diagnosis (PGD) Market Report

1. What was the Preimplantation Genetics Diagnosis (PGD) Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Preimplantation Genetics Diagnosis (PGD) Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Preimplantation Genetics Diagnosis (PGD) Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.